Greer Announces Strategic Relationship with Curalogic; Global Supplier of Source Materials Supporting Next Generation of Allergy Care.

LENOIR, N.C. -- Greer, a leading developer and provider of allergenic source materials and allergy immunotherapy products, is expanding its global reach and commitment to next-generation allergy care through a partnership with Danish biotechnology company Curalogic. Greer will supply Curalogic with customized source materials and analytical support for the development of its oral immunotherapy products.

As part of this new relationship, Greer is supplying short ragweed pollen to Curalogic. The pollen is used to manufacture the company's first product, a capsule for treating ragweed allergies. Greer also supports Curalogic's internal testing by performing analytical testing such as SDS-PAGE, isoelectric focusing (IEF) and measurement of the major allergen Antigen E by radial immunodiffusion (RID).

"We are excited about the opportunity to work with Curalogic as they develop their pipeline of products," says Will Mahoney, director of source materials at Greer. "Greer is well known for providing companies with customized materials--no matter how rare or complex--to meet their research needs."

Greer's source materials business unit specializes in supplying allergenic source materials, such as pollen, dust mites, animal danders and moulds to pharmaceutical and biotech companies in the United States and Europe. In addition to raw materials, Greer also provides allergy extracts in a variety of forms--freeze-dried or liquid intermediates--formulated to satisfy customer-defined specifications.

About Greer

Greer is a leading developer and provider of allergy immunotherapy products, source materials and services for treating humans and animals. Greer's highly skilled scientists provide technical support for customers by continuing to focus on improving the lives of allergic patients. The company was founded in 1904 and is located in Lenoir, North Carolina. To learn more about Greer, its source materials or its other products and services, call [phone] or visit us at www.greerlabs.com.

About Curalogic

Curalogic is a Danish biotechnology company working to develop and revolutionize allergy treatment around the world. Curalogic's proprietary technology makes oral immunotherapy possible through the micro-incapsulation of allergens. This technology is developed at the University of Cincinnati, and Curalogic has a licensing agreement with the university that gives the company sole proprietary rights. Curalogic has a broad pipeline of mature development programs focused on three major allergies: ragweed, grass and house dust mites. More information is available at www.curalogic.com.